US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 2, 2013 (13 years ago)

Pantoprazole Sodium Dr

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mixup: PANTOPRAZOLE SODIUM DR, Tablet, 20 mg may be potentially mislabeled as one of the following drugs: HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD60272_16, EXP: 5/22/2014; MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg, NDC 65162066810, Pedigree: AD73646_13, EXP: 5/30/2014.

What was recalled

PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00008060601.

Recalling firm
Aidapak Services, LLC
Origin
WA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-778-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pantoprazole recalls

See all
Class II · Moderate risk Ongoing

Pantoprazole Sodium

Reason Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."

Hetero Labs Limited (Unit V) NDC 31722-713-10 D-0484-2026
Class II · Moderate risk Terminated

Pantoprazole Sodium for Injection 40mg per vial

Reason Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.

Be Pharmaceuticals Ag NDC 71839-122-01 D-1148-2023
Class II · Moderate risk Completed

Pantoprazole sodium for Injection 40 mg*/vial

Reason CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.

Methapharm Inc NDC 67850-150-10 D-0540-2023
Class II · Moderate risk Terminated

Pantoprazole 30mg in Ns 7.5ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0313-2023